Animal Health



KBA looks to invest in distruptive technologies in health IT, devices and diagnostics.

KBA will consider investment opportunities in the following areas and technologies:

  • Medical devices and diagnostics
         • Class I, II, III devices
         • Pursue shortest development path
  • Drug discovery, development and delivery for all therapeutic areas 
  • Strategic stages of development to key value inflection points
  • Creative opportunities – repurposed/reformulated drugs, orphan indications
  • Technologies that also have an animal health application

Portfolio Story

Portfolio Story Placeholder

Health Outcomes Sciences’ clinical decision support ePRISM® technology helps healthcare institutions reduce the complication rates from procedures, improves patient satisfaction and enables hospitals to better allocate expensive medical resources to patients who need them most. HOS has an exclusive partnership with the American College of Cardiology to translate the ACC risk models to clinical care. 

Learn more